Last $22.94 USD
Change Today -0.40 / -1.71%
Volume 91.0K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 3:51 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John E. Niederhuber M.D.

Director, Member of Compensation Committee and Member of Scientific Review Committee, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 3 different industries.

See Board Relationships
75$175,601

Background*

Dr. John E. Niederhuber, M.D. is an Adjunct Investigator at NCI's Center for Cancer Research. Dr. Niederhuber serves in clinical position on the NIH Clinical Center Medical Staff. He served management and advisory roles and involved in research, through his laboratory on the National Institutes of Health (NIH) campus. He has an extensive experience with cancer research. Prior to coming to NCI, Dr. Niederhuber served as Director of Comprehensive Cancer Center at the University ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

2010-Present
Director, Member of Compensation Committee and Member of Scientific Review Committee
2011-2013
Former Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

Unknown/Other Education 1973
University of Michigan
Unknown/Other Education
Bethany College
ScD
Bethany College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$81,000
Total Calculated Compensation$175,601
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $22.91 USD -0.43

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
William S. Marth Chief Executive Officer, President, Director and Member of Audit Committee
Albany Molecular Research Inc.
--
Peter William Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.